India, March 11 -- image credit- shutterstock

Ahmedabad-based Zydus Lifescienceshas entered into exclusive negotiations to purchasefrom PAI Partners and Amplitude Surgical's management, as well as two minority shareholders, 85.6% of the share capital of Amplitude Surgical,at a price of €6.25 per Amplitude Surgical share.

The acquisition price represents a 80.6% premium over the last closing price as on 10/03/2025 and premia of 88.2% and 92.2% over the 3-month and 6-month volume-weighted average price of Amplitude Surgical respectively.

Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies. The company provides numerous value-added innovations to best meet the needs of patients, surge...